Oct 25, 2017 16:57 pm UTC| Business
HOUSTON, Oct. 25, 2017 -- CADWorx Analysis Solutions will host a webinar on November 7, 2017 at 10:00 a.m. CT that will demonstrate new capabilities and updates in CADWorx 2018 Structure that include new steel and...
Reis, Inc. Adds Land Transactions to Nationwide Sales Comparables Database
Oct 25, 2017 16:56 pm UTC| Business
NEW YORK, Oct. 25, 2017 -- Reis, Inc. (NASDAQ:REIS) (“Reis” or the “Company”), a leading provider of commercial real estate market information and analytical tools, announced today the immediate inclusion of all land...
Oct 25, 2017 16:52 pm UTC| Business
AUCKLAND, New Zealand and MORELIA, Mexico, Oct. 25, 2017 -- Vista Latin America, a subsidiary of Vista Entertainment Solutions Ltd, the world’s leading cinema management software provider to the global cinema exhibition...
uBreakiFix Opens North Houston Location; Spring Marks Eight Greater Houston Stores
Oct 25, 2017 16:49 pm UTC| Business
SPRING, Texas, Oct. 25, 2017 -- uBreakiFix opened in Spring on Saturday, Oct. 21, at 1650 Louetta Road Ste. 250. The fast-growing technology repair brand provides same-day repair service of all electronics, specializing...
NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020
Oct 25, 2017 16:43 pm UTC| Business
REGULATED INFORMATION GHENT, Belgium, 25 October 2017 (6.30 pm CEST) - Ablynx NV [Euronext Brussels: ABLX, NASDAQ: ABLX], a late-stage clinical biopharmaceutical company utilising its proprietary Nanobody® platform...
uBreakiFix Grows Massachusetts Footprint, Opens in Needham
Oct 25, 2017 16:40 pm UTC| Business
NEEDHAM, Mass., Oct. 25, 2017 -- uBreakiFix opens in Needham on Wednesday, Oct. 25, at 225B Highland Ave. The fast-growing technology repair brand provides same-day repair service of all electronics, specializing in...
FDA Recognizes Orphan Drug Exclusivity for Adamas’ GOCOVRI™
Oct 25, 2017 16:31 pm UTC| Business
EMERYVILLE, Calif., Oct. 25, 2017 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Drug Products (OOPD) has recognized by letter to the...